Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study

Area of Science:

• Neuroimaging
• Hematology
• Radiology

Background:

• Beta-thalassemia management requires monitoring for iron overload.
• Iron accumulation in organs like the heart and liver is common.
• Brain iron content monitoring in beta-thalassemia is debated due to conflicting MRI data.

Purpose of the Study:

• To quantitatively assess brain iron content in beta-thalassemia patients using 3T-MRI.
• To investigate potential correlations between iron levels, clinical data, and treatment regimens.
• To clarify the extent and significance of brain iron deposition in beta-thalassemia.

Main Methods:

• A high-resolution whole-brain quantitative MRI assessment of iron (R2*) was performed.
• 47 transfusion-dependent, 23 non-transfusion dependent beta-thalassemia patients, and 57 healthy controls were included.
• Regional R2*-values and hippocampal volumes were analyzed, alongside clinical and cognitive data.

Main Results:

• No significant differences in regional brain iron (R2*) were found between patients and controls, except for lower R2* in patients on deferiprone.
• Whole-brain analysis revealed age-R2* correlations and increased R2* in hippocampal formations and near Luschka foramina in patients.
• Increased R2* values were attributed to a blooming effect near choroid plexuses, not neural tissue iron overload.

Conclusions:

• Concerns regarding neural tissue iron overload in beta-thalassemia appear unjustified based on MRI findings.
• The observed R2* increases are likely due to a blooming artifact, not actual iron deposition in brain tissue.
• This study suggests a re-evaluation of brain iron monitoring protocols in beta-thalassemia patients is warranted.